Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.0460
-0.0010 (-2.13%)
Mar 26, 2026, 3:09 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 69.26 million as of March 25, 2026. Its market cap has decreased by -83.01% in one year.
Market Cap
69.26M
Enterprise Value
-28.65M
Revenue
7.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 69.26M, an increase of 1,790.95%. That is a compound annual growth rate of 10.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 69.26M | -88.67% |
| Dec 31, 2025 | 611.59M | 15.11% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 112.01M |
| Botanix Pharmaceuticals | 95.38M |
| Arovella Therapeutics | 85.71M |
| Alterity Therapeutics | 76.13M |
| Radiopharm Theranostics | 70.88M |
| LTR Pharma | 69.08M |
| Cynata Therapeutics | 68.86M |
| Neurizon Therapeutics | 59.48M |